hesperetin has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, MC; Liou, SS; Liu, IM; Liu, WY | 1 |
| Han, J; Li, J; Li, Z; Liu, T; Wang, M; Wu, M; Zhang, Y; Zhu, X | 1 |
| Eckert, GP; Grewal, R; Keck, CM; Stahr, PL | 1 |
| Chen, S; Chen, X; Fang, L; Li, Z; Liu, T; Wang, M; Zhang, Y; Zheng, Y | 1 |
| Hajizadeh Moghaddam, A; Kheradmand, E; Zare, M | 1 |
| Ali, T; Ikram, M; Jo, MG; Khan, A; Kim, MO; Muhammad, T; Rehman, SU | 1 |
| Huang, SM; Lin, JA; Tsai, SY; Wu, CH; Yen, GC | 1 |
7 other study(ies) available for hesperetin and Alzheimer Disease
| Article | Year |
|---|---|
The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress.
Topics: Alzheimer Disease; Apoptosis; Citrus; Diabetes Mellitus; Endoplasmic Reticulum Stress; Flavonoids; Glycation End Products, Advanced; Hesperidin; Humans | 2022 |
Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cholinesterase Inhibitors; Hesperidin; Inflammation; Ligands; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rats | 2021 |
Investigating hesperetin nanocrystals with tailor-made sizes for the prevention and treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Hesperidin; Humans; Nanoparticles; Solubility | 2021 |
Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Discovery; Hesperidin; Ligands; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotective Agents; Nitric Oxide; Protein Binding; Rats; Transcription Factor RelA; Triazoles | 2021 |
Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hesperidin; Hippocampus; Male; Malondialdehyde; Memory Disorders; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2018 |
Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; Biomarkers; Cell Line; Cognitive Dysfunction; Disease Models, Animal; Hesperidin; Hippocampus; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Neuroprotection; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Synapses; Toll-Like Receptor 4 | 2019 |
Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autophagy; Biological Transport; Cell Line; Cytoprotection; Down-Regulation; Energy Metabolism; Glucose; Glucose Transporter Type 3; Glucose Transporter Type 4; Hesperidin; Mice; Neurons; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2012 |